awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30438282-FF3D865F-6B8D-4B3C-9190-0B19FC400073
Q30438282-FF3D865F-6B8D-4B3C-9190-0B19FC400073
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30438282-FF3D865F-6B8D-4B3C-9190-0B19FC400073
Out of the shadows: CXC chemokines in promoting aberrant lung cancer angiogenesis
P2860
Q30438282-FF3D865F-6B8D-4B3C-9190-0B19FC400073
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30438282-FF3D865F-6B8D-4B3C-9190-0B19FC400073
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5e8fa5e3f2bad38e41a38721162a4debb12f128d
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.